首页 | 本学科首页   官方微博 | 高级检索  
     


Cerebellar infarction risk in a mild COVID-19 case
Authors:Antigona Kabashi  Henri Fero  Artiona Gjini  Diana Dhimitri  Mimoza Spahiu  Fjolla Hyseni  Edlira Harizi  Kledisa Shemsi  Valon Vokshi  Arlind Decka  Asm al Amin  Ahm Ataullah  Livia Capi  Sepideh Jahanian  Fareeha Nasir  Ivan N. Ayala  Juna Musa  Jeton Shatri  Kreshnike Dedushi  Florim Leniqi  Guri Hyseni
Abstract:
Thrombotic events in SARS-COV-2 disease patients are frequent, especially in patients with comorbidities such as heart failure, hypertension, cancer, diabetes mellitus, kidney failure, vascular disease, and other pulmonary illnesses. In severe cases, in particular those of hospitalized patients with other comorbidities, the development of thrombotic events in spite of anticoagulation therapy has been observed. The main thrombotic events are pulmonary thromboembolism, cerebral ischemic stroke, and peripheral artery thrombosis. Despite the severity of SARS-COV-2 disease, some patients with the aforementioned comorbidities develop thrombotic events regardless of the severity of their SARS-COV-2 infection. In this setting, the cerebellum makes no exception as an uncommon, but still possible target for thrombotic events.
Keywords:Cerebellar infarction   COVID-19   SARS-COV-2   Pulmonary thromboembolism   SARS-COV-2 infection   Role of MRI
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号